Pubmed    Pubmed Central		uBio Home | uBioRSS
WebSearch Literature Molecular Images

uBio  Web  Results 71 - 80 of about 863 Synonyms:    Cloridina verrucosa  Broader Terms:    Cloridina      Latest Articles on Cloridina verrucosa (Hansen 1926) from uBioRSS Squilla Fabricius, 1787 - WoRMS latest taxa marked as checked Squilla verrucosa Hansen, 1926 - WoRMS latest taxa marked as checked 71.  Third-party verification of total and specific immunoglobulin E on analyzer Immulite® 2000XPi. Vuljani? D, Duki? L, Krle?a JL, Juro? GF, Pozai? P, ?imundi? AM Clinica chimica acta; international journal of clinical chemistry, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 72.  Cutaneous tuberculosis in Rio de Janeiro, Brazil: description of a series of 75 cases. Mann D, Sant'Anna FM, Schmaltz CAS, Rolla V, Freitas DFS, Lyra MR, Sampaio FMS, do Valle ACF, Lourenço MCS, Quintella LP, Teichner TC, Cavalcante SC, Galhardo MCG International journal of dermatology Int J Dermatol Cutaneous tuberculosis in Rio de Janeiro, Brazil: description of a series of 75 cases. 1451-1459 10.1111/ijd.14617 Brazil is one of the highest tuberculosis (TB) burden countries of the world. Cutaneous tuberculosis (CTB) is a rare form of extrapulmonary manifestation of tuberculosis. This study aimed to describe the clinico-evolutive, laboratory and therapeutic aspects of CTB cases among patients from a cohort with TB in Rio de Janeiro, Brazil. Cases of diagnosed CTB with microbiologic confirmation or clinical response to anti-tuberculous treatment associated with positive smear or histopathological findings between the years 2000 and 2016 were selected. Seventy-five patients with CTB were included, most were women (58.7%) with a median age of 42 years. CTB diagnosis was based on culture in only 42.7% of the cases. Scrofuloderma represented 50.7% of the cases, followed by erythema induratum of Bazin (EIB) (18.7%), tuberculous gumma (13.3%), lupus vulgaris (8%), TB verrucosa cutis (4%), orificial TB (2.7%) and associated forms (2.7%). Other TB presentations were pulmonary (22.7%), mammary (6.6%) and osteoarticular (4%). All patients who completed the treatment (97.3%) had their lesions healed. Only two patients (2.6%) needed to change the therapy due to adverse reactions. Fifty percent of EIB patients presented recurrence. These data highlight the diversity of CTB presentations and the importance of the skin to assist in early identification and treatment of TB. More studies are necessary to improve the knowledge on EIB for a better approach towards these patients, mainly in cases of recurrence. © 2019 The International Society of Dermatology. Mann Danielle D Post Graduation of Clinical Research on Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Sant'Anna Flavia M FM Laboratory of Clinical Research in Mycobacteriosis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Schmaltz Carolina A S CAS Laboratory of Clinical Research in Mycobacteriosis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Rolla Valeria V Laboratory of Clinical Research in Mycobacteriosis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Freitas Dayvison F S DFS Laboratory of Clinical Research in Infectious Dermatology, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Lyra Marcelo R MR Laboratory of Clinical Research in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Sampaio Felipe M S FMS Laboratory of Clinical Research in Infectious Dermatology, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. do Valle Antonio C F ACF Laboratory of Clinical Research in Infectious Dermatology, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Lourenço Maria C S MCS Laboratory of Bacteriology and Bioassays, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Quintella Leonardo P LP Anatomical Pathology Service, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Teichner Tullia C TC Anatomical Pathology Service, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Cavalcante Solange C SC Laboratory of Clinical Research in Mycobacteriosis, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Galhardo Maria C G MCG Laboratory of Clinical Research in Infectious Dermatology, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. eng No number Coordenação de Aperfeiçoamento de Pessoal de Nível Superior UNODC 01/2013 Clinical Research Laboratory on Mycobacteria of the National Institute of Infectious Disease Journal Article 2019 09 25 England Int J Dermatol 0243704 0011-9059 0 Antitubercular Agents IM Adolescent Adult Aged Aged, 80 and over Antitubercular Agents therapeutic use Brazil epidemiology Cohort Studies Female Humans Male Middle Aged Mycobacterium tuberculosis isolation & purification Prospective Studies Skin microbiology pathology Treatment Outcome Tuberculosis, Cutaneous drug therapy epidemiology microbiology pathology Tuberculosis, Osteoarticular drug therapy epidemiology microbiology Tuberculosis, Pulmonary drug therapy epidemiology microbiology Young Adult 2019 04 15 2019 06 12 2019 08 08 2019 9 26 6 0 2020 5 6 6 0 2019 9 26 6 0 ppublish 31553059 10.1111/ijd.14617